Overview

Therapy of Essential Hypertension With Kinzal®/ Kinzalplus®

Status:
Completed
Trial end date:
2011-10-01
Target enrollment:
Participant gender:
Summary
The efficacy and tolerability of an antihypertensive treatment with Telmisartan is followed over 3-4 months
Details
Lead Sponsor:
Bayer
Treatments:
Hydrochlorothiazide
Telmisartan